ARTICLE | Clinical News
Extended-release oxymorphone regulatory update
November 1, 2010 7:00 AM UTC
FDA's Anesthetic and Life Support Drugs and Drug Safety and Risk Management advisory committees will meet on Dec. 2 to discuss an NDA from Endo for an extended-release, crush-resistant formulation of ...